Company: KROS
Filing Date: 2025-04-10
Form Type: 8-K
Source: 0001664710-25-000033
Chunk: 8

Company: Keros Therapeutics, Inc.
Filing Date: 2025-04-10
Form: 8-K
Item: Item 9.01
Chunk 8
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

  Exhibit                                                                                                                                                                                                            
  No.          Description                                                                                                                                                                                           
  3.1          Certificate of Designation of Series A Junior Participating Preferred Stock filed with the Secretary of State of the State of Delaware on April 9, 2025                                               
  4.1*         Rights Agreement, dated as of April 9, 2025 between Keros Therapeutics, Inc. and Computershare Trust Company, N. A., which includes the form of Certificate of Designation as Exhibit A, the form...  
  99.1         Press release dated April 10, 2025                                                                                                                                                                    
  104          Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document)                                                                                              

* Certain exhibits omitted pursuant to Item 601(b)(2) of Regulation S-K. Keros will furnish supplementally a copy of any omitted exhibit to the SEC upon request. Keros may request confidential treatment pursuant to Rule 24b-2 of the Exchange Act for any exhibits so furnished

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  KEROS THERAPEUTICS, INC.                               
  By:                           /s/ Jasbir Seehra        
                                Jasbir Seehra, Ph. D.    

Dated: April 10, 2025